Mucus models to evaluate nanomedicines for diffusion

Drug Discovery Today

Volumn 19, Issue 8, 2014, Pages 1097-1108

  Groo, Anne Claire ^a,b   Lagarce, Frederic ^a,c  

^a UNIVERSITÉ D'ANGERS   (France)

^b Ethypharm ^*  (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CHITOSAN; CLARITHROMYCIN; ENOXAPARIN; IBUPROFEN; MACROGOL; MUCIN; PACLITAXEL; POLOXAMER; DRUG; NANOPARTICLE;

COLLOID; COMPARATIVE STUDY; DIFFUSION; DRUG DESIGN; HUMAN; HYDRATION; MODEL; MUCOADHESION; MUCUS; MUCUS MODEL; NANOMEDICINE; NONHUMAN; PARTICLE SIZE; REVIEW; STANDARD; ANIMAL; DRUG DELIVERY SYSTEM; METABOLISM; PROCEDURES;

ANIMALS; DIFFUSION; DRUG DELIVERY SYSTEMS; HUMANS; MUCUS; NANOMEDICINE; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS;

EID: 84906309496     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.01.011     Document Type: Review

References (106)

1. B.Y. Kim et al. Nanomedicine N. Engl. J. Med. 363 2010 2434 2443
2. N. Bertrand, and J.C. Leroux The journey of a drug-carrier in the body: an anatomo-physiological perspective J. Control. Release 161 2012 152 163
3. K. Khanvilkar et al. Drug transfer through mucus Adv. Drug Deliv. Rev. 48 2001 173 193
4. K. Hida et al. Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients PLoS ONE 6 2011 e19919
5. A.W. Larhed et al. Diffusion of drugs in native and purified gastrointestinal mucus J. Pharm. Sci. 86 1997 660 665
6. P.G. Bhat et al. The limiting role of mucus in drug absorption: drug permeation through mucus solution Int. J. Pharm. 126 1995 179 187
7. D.A. Norris, and P.J. Sinko Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin J. Appl. Polym. Sci. 63 1997 1481 1492
8. J.S. Crater, and R.L. Carrier Barrier properties of gastrointestinal mucus to nanoparticle transport Macromol. Biosci. 10 2010 1473 1483
9. S.L. McGill, and H.D. Smyth Disruption of the mucus barrier by topically applied exogenous particles Mol. Pharm. 7 2010 2280 2288
10. P.C. Griffiths et al. PGSE-NMR and SANS studies of the interaction of model polymer therapeutics with mucin Biomacromolecules 11 2010 120 125
11. P. Grubel, and D.R. Cave Factors affecting solubility and penetration of clarithromycin through gastric mucus Aliment. Pharmacol. Ther. 12 1998 569 576
12. M. Dawson et al. Transport of polymeric nanoparticle gene carriers in gastric mucus Biotechnol. Prog. 20 2004 851 857
13. A.W. Larhed et al. The influence of intestinal mucus components on the diffusion of drugs Pharm. Res. 15 1998 66 71
14. X. Li et al. Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake Int. J. Nanomedicine 6 2011 3151 3162
15. L.R. Shaw et al. The influence of excipients on the diffusion of ibuprofen and paracetamol in gastric mucus Int. J. Pharm. 290 2005 145 154
16. P.G. Bhat et al. Drug diffusion through cystic fibrotic mucus: steady-state permeation, rheologic properties, and glycoprotein morphology J. Pharm. Sci. 85 1996 624 630
17. J. Kirch et al. Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus Proc. Natl. Acad. Sci. U. S. A. 109 2012 18355 18360
18. S.K. Lai et al. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses Proc. Natl. Acad. Sci. U. S. A. 107 2010 598 603
19. S.K. Lai et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus Proc. Natl. Acad. Sci. U. S. A. 104 2007 1482 1487
20. Y.Y. Wang et al. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier Angew. Chem. Int. Ed. 47 2008 9726 9729
21. W.M. Saltzman et al. Antibody diffusion in human cervical mucus Biophys. J. 66 Pt 1 1994 508 515
22. S.K. Lai et al. Altering mucus rheology to "solidify" human mucus at the nanoscale PLoS ONE 4 2009
23. B.C. Tang et al. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier Proc. Natl. Acad. Sci. U. S. A. 106 2009 19268 19273
24. S. Mura et al. Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells Biomacromolecules 12 2011 4136 4143
25. O. Mert et al. A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles J. Control. Release 157 2012 455 460
26. S.S. Olmsted et al. Diffusion of macromolecules and virus-like particles in human cervical mucus Biophys. J. 81 2001 1930 1937
27. B.S. Schuster et al. Nanoparticle diffusion in respiratory mucus from humans without lung disease Biomaterials 34 2013 3439 3446
28. J.S. Suk et al. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles Biomaterials 30 2009 2591 2597
29. N.N. Sanders et al. Cystic fibrosis sputum: a barrier to the transport of nanospheres Am. J. Respir. Crit. Care Med. 162 2000 1905 1911
30. S.K. Lai et al. Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus Biomaterials 32 2011 6285 6290
31. T. Lesuffleur et al. Dihydrofolate reductase gene amplification- associated shift of differentiation in methotrexate-adapted HT-29 cells J. Cell Biol. 115 1991 1409 1418
32. I. Behrens et al. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport Pharm. Res. 19 2002 1185 1193
33. C. Pontier et al. HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer J. Pharm. Sci. 90 2001 1608 1619
34. T. Lesuffleur et al. Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations J. Cell Sci. 106 1993 771 783
35. L. Poquet et al. Transport and metabolism of ferulic acid through the colonic epithelium Drug Metab. Dispos. 36 2008 190 197
36. I. Behrens et al. Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells Pharm. Res. 18 2001 1138 1145
37. G.J. Mahler et al. Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability J. Nutr. Biochem. 20 2009 494 502
38. C. Meaney, and C. O'Driscoll Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models Eur. J. Pharm. Sci. 8 1999 167 175
39. N.G.M. Schipper et al. Chitosans as absorption enhancers of poorly absorbable drugs. 3. Influence of mucus on absorption enhancement Eur. J. Pharm. Sci. 8 1999 335 343
40. J. Karlsson et al. The mucus layer as a barrier to drug absorption in monolayers of human intestinal epithelial HT29-H goblet cells Int. J. Pharm. 99 1993 209 218
41. D. Vllasaliu et al. Barrier characteristics of epithelial cultures modelling the airway and intestinal mucosa: a comparison Biochem. Biophys. Res. Commun. 415 2011 579 585
42. X.M. Chen et al. Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design J. Pharmacol. Toxicol. Methods 61 2010 334 342
43. E. Walter et al. HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans J. Pharm. Sci. 85 1996 1070 1076
44. A. Wikman-Larhed, and P. Artursson Co-cultures of human intestinal goblet (HT29-H) and absorptive (Caco-2) cells for studies of drug and peptide absorption Eur. J. Pharm. Sci. 3 1995 171 183
45. C. Wadell et al. Nasal drug delivery - evaluation of an in vitro model using porcine nasal mucosa Eur. J. Pharm. Sci. 7 1999 197 206
46. S. Takatsuka et al. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant Eur. J. Pharm. Biopharm. 62 2006 52 58
47. V. Zabaleta et al. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study Eur. J. Pharm. Biopharm. 81 2012 514 523
48. B. Petit et al. The counterbalanced effect of size and surface properties of chitosan-coated poly(isobutylcyanoacrylate) nanoparticles on mucoadhesion due to pluronic F68 addition Pharm. Res. 29 2012 943 952
49. M. Agüeros et al. Combined hydroxypropyl-β-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel Eur. J. Pharm. Sci. 38 2009 405 413
50. Y. Jin et al. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport Biomaterials 33 2011 1573 1582
51. C. He et al. Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs Biomaterials 33 2012 8569 8578
52. L. Szentkuti Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon J. Control. Release 46 1997 233 242
53. P.D.P. Lundin et al. Enhancing effects of monohexanoin and two other medium-chain glyceride vehicles on intestinal absorption of desmopressin (dDAVP) J. Pharmacol. Exp. Ther. 282 1997 585 590
54. W. Xiao et al. Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer Int. J. Nanomedicine 7 2012 1587 1597
55. A. Mistry et al. Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium J. Drug Target. 17 2009 543 552
56. L.M. Ensign et al. Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake Biomaterials 34 2013 6922 6929
57. L.M. Ensign et al. Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus Sci. Transl. Med. 4 2012 138 179
58. P.G. Bhat et al. Drug binding to gastric mucus glycoproteins Int. J. Pharm. 134 1996 15 25
59. E.R. Boskey et al. A self-sampling method to obtain large volumes of undiluted cervicovaginal secretions Sex. Transm. Dis. 30 2003 107 109
60. T.T. Kararli Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals Biopharm. Drug Dispos. 16 1995 351 380
61. A-C. Groo et al. Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery Int. J. Nanomedicine 8 2013 4291 4302
62. F.J. Fogg et al. Characterization of pig colonic mucins Biochem. J. 316 1996 937 942
63. ++ Biorheology 24 1987 625 633
64. E.Y. Chen et al. A new role for bicarbonate in mucus formation Am. J. Physiol. Lung Cell. Mol. Physiol. 299 2010 L542 L549
65. M.L. Aitken, and P. Verdugo Donnan mechanism of mucin release and conditioning in goblet cells: the role of polyions Symp. Soc. Exp. Biol. 43 1989 73 80
66. O. Lieleg et al. Characterization of particle translocation through mucin hydrogels Biophys. J. 98 2010 1782 1789
67. H. Matsui et al. A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms Proc. Natl. Acad. Sci. U. S. A. 103 2006 18131 18136
68. L.M. Ensign et al. Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues Mol. Pharm. 10 2013 2176 2182
69. L.M. Ensign et al. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers Adv. Drug Deliv. Rev. 64 2012 557 570
70. H. Hosseinzadeh et al. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study Int. J. Nanomedicine 7 2012 1851 1863
71. C. Mûller et al. Thiopyrazole preactivated chitosan: combining mucoadhesion and drug delivery Acta Biomater. 9 2013 6585 6593
72. S. Jain et al. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel Biomaterials 33 2012 6758 6768
73. I. Ezpeleta et al. Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal mucus Int. J. Pharm. 191 1999 25 32
74. J. Apgar et al. Multiple-particle tracking measurements of heterogeneities in solutions of actin filaments and actin bundles Biophys. J. 79 2000 1095 1106
75. J. Suh et al. Real-time multiple-particle tracking: applications to drug and gene delivery Adv. Drug Deliv. Rev. 57 2005 63 78
76. Y.Y. Wang et al. Mucoadhesive nanoparticles may disrupt the protective human mucus barrier by altering its microstructure PLoS ONE 6 2011 e21547
77. I. Bravo-Osuna et al. Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles Eur. J. Pharm. Biopharm. 69 2008 436 444
78. J. Kowapradit et al. Methylated N-(4-N,N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivery Eur. J. Pharm. Sci. 47 2012 359 366
79. S.S. Chakravarthi, and D.H. Robinson Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles Int. J. Pharm. 409 2011 111 120
80. P. Occhipinti, and P.C. Griffiths Quantifying diffusion in mucosal systems by pulsed-gradient spin-echo NMR Adv. Drug Deliv. Rev. 60 2008 1570 1582
81. A.-C. Groo et al. Development of 2D and 3D mucus models and their interactions with mucus penetrating paclitaxel loaded lipid nanocapsules Pharm. Res. 2014 10.1007/s11095-013-1280-4 (in press)
82. C. Prego et al. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery Pharm. Res. 23 2006 549 556
83. H. Lian et al. Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism Mol. Pharm. 10 2013 3447 3458
84. L. Wang et al. Exploration of hydrophobic modification degree of chitosan-based nanocomplexes on the oral delivery of enoxaparin Eur. J. Pharm. Sci. 50 2013 263 271
85. N.J. Boylan et al. Highly compacted DNA nanoparticles with low MW PEG coatings: in vitro, ex vivo and in vivo evaluation J. Control. Release 157 2012 72 79
86. N.N. Sanders et al. The physical properties of biogels and their permeability for macromolecular drugs and colloidal drug carriers J. Pharm. Sci. 89 2000 835 849
87. A.R. Gordon The diaphragm cell method of measuring diffusion Ann. N. Y. Acad. Sci. 46 1945 285 308
88. J. Dainty, and C.R. House An examination of the evidence for membrane pores in frog skin J. Physiol. 185 1966 172 184
89. J. Dainty, and C.R. House Unstirred layers in frog skin J. Physiol. 182 1966 66 78
90. T. Korjamo et al. Analysis of unstirred water layer in in vitro permeability experiments J. Pharm. Sci. 98 2009 4469 4479
91. J. Dainty Water Relations of Plant Cells 1963 London Academic Press
92. X. Cao et al. pH-dependent conformational change of gastric mucin leads to sol-gel transition Biophys. J. 76 1999 1250 1258
93. A.I. Yudin et al. Human cervical mucus and its interaction with sperm: a fine-structural view Biol. Reprod. 40 1989 661 671
94. G. Mythri et al. Novel mucoadhesive polymers - a review JAPS 1 2011 37 42
95. F.A. Moghaddam et al. Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticles Nanomedicine 5 2009 208 215
96. K. Gradauer et al. Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties Int. J. Nanomedicine 7 2012 2523 2534
97. ®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats Int. J. Pharm. 449 2013 1 9
98. C.A. Silva et al. Interaction of chitosan and mucin in a biomembrane model environment J. Colloid Interface Sci. 376 2012 289 295
99. K. Yoncheva et al. Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties Eur. J. Pharm. Sci. 24 2005 411 419
100. K. Yoncheva et al. Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles Int. J. Pharm. 334 2007 156 165
101. Y. Huang et al. Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces J. Control. Release 65 2000 63 71
102. Q. Xu et al. Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus J. Control. Release 170 2013 279 286
103. H. Yuan et al. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles Mol. Pharm. 10 2013 1865 1873
104. V.J. Broughton-Head et al. Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics Pulm. Pharmacol. Ther. 20 2007 708 717
105. C. Müller et al. Preparation and characterization of mucus-penetrating papainpoly(acrylic acid) nanoparticles for oral drug delivery applications J. Nanopart. Res. 15 2013 1 13
106. L.M. Ensign et al. Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery Adv. Mater. 24 2012 3887 3894